Skip to main content
. 2021 Aug 12;16(8):e0255782. doi: 10.1371/journal.pone.0255782

Table 2. Infections averted in the general population with 5-day testing and one-time testing of students compared to a policy of no routine asymptomatic testing (symptom-based surveillance and contact tracing only).

5-day testing compared to no routine testing One-time testing three weeks after student arrival compared to no routine testing
Scenario Without students With students Infections averted % averted in the general pop’n Critical care adm’n averted COVID-19 deaths averted Infections averted % averted in the general pop’n Critical care adm’n averted COVID-19 deaths averted
31% asymptomatic in students
 Base case physical distancing (40% reduction in contacts immediately) 3,515 7,551 1,685 68% 19.3 15.0 102 76% 1.3 1.0
 Two weeks of 2.0x activity among students, followed by 40% reduction in contacts 3,515 11,169 2,873 64% 31.3 24.3 290 66% 3.2 2.5
 Low level of physical distancing (24% reduction in contacts immediately) 3,515 14,263 5,451 57% 52.5 40.8 186 63% 2.0 1.5
 Two weeks of 2.0x activity among students, followed by 40% reduction in contacts; 50% of general population engaged in high-intensity physical distancing 649 8,018 4,266 63% 45.6 35.4 343 65% 3.8 2.9
50% asymptomatic in students
 Base case physical distancing (40% reduction in contacts immediately) 3,515 7,632 1,768 67% 20.2 15.7 51 69% 0.6 0.5
 Two weeks of 2.0x activity among students, followed by 40% reduction in contacts 3,515 11,076 2,789 62% 29.6 23.0 329 66% 3.7 2.9
80% asymptomatic in students
 Base case physical distancing (40% reduction in contacts immediately) 3,515 7,794 1,934 67% 22.0 17.1 69 71% 0.8 0.7
 Two weeks of 2.0x activity among students, followed by 40% reduction in contacts 3,515 11,514 3,238 64% 35.0 27.2 419 68% 4.9 3.8

Scenarios vary the proportion of infections in the student population that are asymptomatic and timing and level of students contact reductions. We calculate the expected number of critical care admissions averted and COVID-19 deaths averted to be 1.7% and 1.32% of general population infections averted which includes hospitalizations and deaths which may occur after December 31 to all individuals infected prior to December 31. The economic value of testing strategies is presented in Appendix Table 7 in S1 File.